ORGANIZATION
Wholesalers to Address Product Return Issue after Fake Harvoni Case: JPWA Chair
Ken Suzuki, president of the Federation of Japan Pharmaceutical Wholesalers Association (JPWA), in a recent interview aired his frustration over the discovery of counterfeit Harvoni (ledipasvir + sofosbuvir) earlier this year, saying it has marred his international commitment to the…
To read the full story
ORGANIZATION
- Industry Hails Japan Growth Roadmap, PhRMA Urges Follow-Through
June 25, 2026
- Boehringer’s Hasson Appointed EFPIA Japan Vice Chair
June 22, 2026
- Think Tank Opposes Cap on Social Security Burden Ratio, Urges Pause in Off-Year Price Cuts
June 22, 2026
- Japanese Drug Makers Step Up Use of ASEAN Reliance Reviews
June 18, 2026
- Ease Foreign Price Adjustment Rules for New Drugs to Counter MFN Policy: FPMAJ
June 15, 2026
Recent trends are creating a fascinating push-and-pull effect in the talent market. We’re seeing more positions opening up, but also a greater number of candidates available, particularly in the fields of rare diseases and oncology. This “more positions, more candidates”…





